A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease-Reference-Cited by-同舟云学术

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease

Published:2010-12-28 Issue:9 Volume:26 Page:937-943
ISSN:0885-6230
Container-title:International Journal of Geriatric Psychiatry
language:en
Short-container-title:Int. J. Geriat. Psychiatry

Author:

Devanand D.P.,Pelton Gregory H.,Cunqueiro Karine,Sackeim Harold A.,Marder Karen

Publisher

Wiley

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gps.2630/fullpdf

Reference37 articles.

1. Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (The CALM-AD trial);Ballard;Am J Geriatr Psychiatry,2009a

2. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial;Ballard;Lancet Neurol,2009b

3. A randomised, blinded, placebo-controlled trial in dementia patients continuing to take or discontinued from treatment with neuroleptics (the DARTAD trial);Ballard;PLoS Med,2008

4. A 3-month, randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cutoff is a predictor of clinical outcome;Ballard;J Clin Psychiatry,2004

5. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects;Blessed;Br J Psychiatry,1968

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Trajectory of Long-Term Antipsychotic Medication Dosage in Inpatients with Severe Behavioral and Psychological Symptoms of Dementia: A Retrospective Study;Pharmacopsychiatry;2024-06-25

2. Psychotic Symptoms and Syndromes;Age-Adjusted Psychiatric Treatment for the Older Patient;2024

3. Neuropsychiatric Symptoms of Major or Mild Neurocognitive Disorders;Geriatric Psychiatry;2024

4. Drug repositioning with adaptive graph convolutional networks;Bioinformatics;2023-12-09

5. Scoping Review of Randomized Trials With Discontinuation of Medicines in Older Adults;Journal of the American Medical Directors Association;2022-12